Cholesterol Test Kits Market, By Product Type (Test Strip Kits, and Analyzer Kits), By Test (Total Cholesterol Test, HDL Cholesterol Test, LDL Cholesterol Test, Triglycerides/VLDL Cholesterol Test, and Others), By End-user (Clinics, Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Diagnostic Centers), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2029

Cholesterol is a wax-like, fatty substance found in our body. The liver prepares and quantifies the cholesterol needed by the body consistent with the need. The additional cholesterol produce is termed as bad cholesterol. If the cholesterol level exceeds the specified quantity within the body, it can build abreast of walls of arteries termed as plaque and eventually harden. This process is named atherosclerosis. Atherosclerosis narrows the arteries, making it harder for blood to travel through the vessels, resulting in cardiovascular diseases. Unfortunately, high cholesterol doesn't cause symptoms. In later stages of atherosclerosis, it's going to cause a private to suffer angina -- severe pain from lack of blood flow to the guts. If an artery gets totally blocked, it may result during a heart failure. According to FDA, the total cholesterol level should be 200mg/dL or less, according to recommendations in the National Cholesterol Education Program (NCEP) Third Adult Treatment Panel (ATP III). According to the NCEP, the recommended LDL values should be less than 100 mg/dL, HDL values greater or equal to 40 mg/dL, and triglyceride values less than 150 mg/dL. The Cholesterol Test Kits Market accounted for US$ XX billion in 2020 and is estimated to be US$ XX billion by 2029 and is anticipated to register a CAGR of XX.

Impact of Covid-19 pandemic on market

With the outbreak of the COVID-19, various businesses are at the forefront to combat this pandemic. The pandemic has hindered the industrial supply chain and also disrupted the product segment. Government across the countries has imposed strict lockdown to limit the spread of disease. The most common concern for the governments of all Covid-19 hit nations is that the excruciating got to screen for and test large numbers of patients for possible to this infection. As a result, most of them face major shortages within the supply for diagnostic kits to check for the virus. Diagnostics virology entities are under immense pressure to supply reliable testing kits, and there's a surge in demand for in-vitro or point-of-care testing capacities by labs across an outsized number of nations. This report will quantify the impact of pandemic on cholesterol test kits market.

Rising prevalence of cardiovascular diseases and obesity is expected to significantly fuel the demand for cholesterol testing products and services. Population above 18 years of age is recommended to undergo blood cholesterol testing every five years. Patients with a history of heart attacks require cholesterol screening on a regular basis to monitor the effectiveness of their treatment. As recommended by the National Heart, Lung, and Blood Institute, cholesterol testing should be done at least once between the age of 9 to 11 and 17 to 21. According to the Centers for Disease Control and Prevention (CDC), adults between the ages of 40 to 59 have the highest level of total cholesterol, which is 17.1%. This is mainly attributed to the sedentary lifestyle leading to the development of numerous diseases, such as obesity, diabetes, and heart diseases. Increased awareness regarding routine testing and management of healthy cholesterol levels is anticipated to drive the demand for diagnostic products and services.

Increasing geriatric population

The aging population is increasing worldwide, with the most rapid growth in low- and middle-income countries. About 185 million people were above 60 years of age in 2015 (15.7% of the population), and this number is expected to touch 487 million by 2053 (36.5% of the population). Moreover, around 857,040 of the older population is likely to reside in Asia by 2050. In 2016, approximately 18% and 2.4% of the total population in the UK were aged over 65 years and 85 years, respectively. However, the emergence of noninvasive cholesterol testing methods might be hampering the market.

 

The global cholesterol test kits market is segmented based on product type, test, end-user and region.

On the basis of product type, the global cholesterol test kits market is segmented into test strip kits, and analyzer kits. Based on test, the target market is segmented into total cholesterol test, HDL cholesterol test, LDL cholesterol test, triglycerides/VLDL cholesterol test, and others. Based on end-user, the target market segmented into clinics, hospitals, ambulatory surgical centers, home care settings, and diagnostic centers.

On region the Global Cholesterol Test Kits Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the largest revenue share in 2018 due to the rise in prevalence of heart diseases and obesity in the U.S. According to the United Health Foundation's annual report, in the U.S., the obesity rate increased from 29.9% in 2017 to 31.3% in 2018. In addition, the growing preference for preventive healthcare is also projected to drive regional growth. Growing awareness and efforts from the government and various organizations are expected to fuel the market growth. The Asia Pacific is expected to witness lucrative growth over the forecast period owing to the rise in population in this region. Asia accounts for around 60% of the world’s population. Increasing cardiovascular diseases is another factor driving the regional market growth. The rise in the number of new diagnostic centres and pathological laboratories is also expected to foster the regional demand for cholesterol testing products and services.

Report Scope:

Attribute	Details
Base year for estimation	2020
Forecast period	2020 – 2029
Market representation	Revenue in USD Million & CAGR from 2020 – 2029
Market Segmentation	By Product Type- Test Strip Kits and Analyzer Kits By Test- Total Cholesterol Test, HDL Cholesterol Test, LDL Cholesterol Test, Triglycerides/VLDL Cholesterol Test, and Others By End-user- Clinics, Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Diagnostic Centers
Delivery Mode Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global cholesterol test kits market report based on product type, test, end-user, and region.

Global Cholesterol Test Kits Market, By Product type:

• Test Strip Kits
• Analyzer Kits

Global Cholesterol Test Kits Market, By Test:

• Total Cholesterol Test
• HDL Cholesterol Test
• LDL Cholesterol Test
• Triglycerides/VLDL Cholesterol Test
• Others

Global Cholesterol Test Kits Market, By End-user:

• Clinics
• Hospitals
• Ambulatory Surgical Centers
• Home Care Settings
• Diagnostic Centers

Global Cholesterol Test Kits Market, By Region:

• • • North America
      • • U.S.
        • Canada
    • Europe
      • • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

The key players operating in the global cholesterol test kits market includes Quest Diagnostics Incorporated, Cell Biolabs, Inc., Clinical Reference Laboratory, Inc., Laboratory Corporation of America Holdings, Randox Laboratories Ltd., Thermo Fisher Scientific, PTS DIAGNOSTICS, Alere Inc., Hoffmann-La Roche AG, and Eurofins Scientific. The market is especially characterized by collaborations and partnerships between the businesses and acquisitions of smaller players as a part of strategic expansion as well as launching their new product specimen. For instance, in 2017, Quest Diagnostics introduced a novel, nonfasting cholesterol testing with improved LDL calculation method for improved accuracy and patient comfort.

• Quest Diagnostics Incorporated
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Cell Biolabs, Inc.
• Clinical Reference Laboratory, Inc.
• Laboratory Corporation of America Holdings
• Randox Laboratories Ltd.
• Thermo Fisher Scientific
• PTS DIAGNOSTICS
• Alere, Inc.
• Hoffmann-La Roche AG
• Eurofins Scientific

Research Objective and Assumption

• Preface
• Research Objectives
• Study Scope
• Years Considered for the study
• Assumptions
• Abbreviations

Research Methodology

• Research data
• Primary Data
  • Primary Interviews
  • Primary Breakdown
  • Key data from Primary Sources
  • Key Thickness Insights
• Secondary Data
  • Major Secondary Sources
  • Secondary Sources
• Market Estimation
• Top-Down Approach
  • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
• Bottom-Up Approach
  • Approach for estimating market share by Bottom-up Analysis (Demand Side)
• Market Breakdown and Data Triangulation
• Research Assumptions

Market Preview

• Executive Summary
• Key Findings—Global Outlook for medical carts Strategies
  • Key Questions this Study will Answer
  • Market Snippet,  By Product Type
  • Market Snippet, By Test
  • Market Snippet, By End-user
  • Market Snippet, By Region
• Opportunity Map Analysis
• Executive Summary—3 Big Predictions

Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restrains
  • Market Opportunities
  • Market Trends
• DR Impact Analysis
• PEST Analysis
• Porter’s Five Forces Analysis
• Opportunity Orbit
• Market Investment Feasibility Index
• Macroeconomic Factor Analysis

Cholesterol Test Kits Market, By Product Type, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Test Strip Kits
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Analyzer Kits
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Cholesterol Test Kits Market, By Test, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Total Cholesterol Test
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• HDL Cholesterol Test
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• LDL Cholesterol Test
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Triglycerides/VLDL Cholesterol Test
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Diagnostic Centers
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Cholesterol Test Kits Market, By End-user, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Clinics 
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Hospitals
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Ambulatory Surgical Centers
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Home Care Settings
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Diagnostic Centers
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Cholesterol Test Kits Market, By Region, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Regional Trends
• North America
  • Market Size and Forecast (US$ Bn),  By Product Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Test, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End-user, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • U.S.
    • Canada
• Europe
  • Market Size and Forecast (US$ Bn),  By Product Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Test, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End-user, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • UK
    • France
    • Germany
    • Russia
    • Italy
    • Rest of Europe
• Asia Pacific
  • Market Size and Forecast (US$ Bn),  By Product Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Test, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End-user, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • India
    • Japan
    • South Korea
    • China
    • Rest of Asia Pacific
• Latin America
  • Market Size and Forecast (US$ Bn),  By Product Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Test, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End-user, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
  • Market Size and Forecast (US$ Bn),  By Product Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Test, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End-user, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
• GCC
• Israel
• South Africa
• Rest of Middle East

Competitive Landscape

• Heat Map Analysis
• Market Presence and Specificity Analysis

Company Profiles

• Quest Diagnostics Incorporated.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Cell Biolabs, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Clinical Reference Laboratory, Inc..
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Laboratory Corporation of America Holdings
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Randox Laboratories Ltd.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Thermo Fisher Scientific.  
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• PTS DIAGNOSTICS, Alere Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Hoffmann-La Roche AG   
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Eurofins Scientific   
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

The Last Word

• Future Impact
• About Us
• Contact